Biotech · Private company
Baxalta now part of Shire
Track this companyFree. Adds Baxalta now part of Shire to your Dealase workspace and tells you when its record changes.
Clinical trials252 recruiting or active
Pipeline programs28From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline28
- Antihemophilic Factor (Recombinant)Phase 3 · Von Willebrand DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802)Phase 3 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- Antihemophilic factor, recombinant, manufactured protein-freePhase 3 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- GLASSIAPhase 3 · Alpha1-antitrypsin DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- HYQVIAPhase 3 · Primary Immunodeficiency Diseases (PID)ClinicalTrials.gov · fetched Nov 12, 2026
- HYQVIAPhase 3 · Chronic Inflammatory Demyelinating PolyradiculoneuropathyClinicalTrials.gov · fetched Nov 12, 2026
- IGIV GAMMAGARD LIQUID/KIOVIGPhase 3 · Chronic Inflammatory Demyelinating PolyradiculoneuropathyClinicalTrials.gov · fetched Nov 12, 2026
- IGIV GAMUNEX®-CPhase 3 · Chronic Inflammatory Demyelinating PolyradiculoneuropathyClinicalTrials.gov · fetched Nov 12, 2026
- Immune Globulin Intravenous (Human), 10%Phase 3 · Primary Immunodeficiency Diseases (PID)ClinicalTrials.gov · fetched Nov 12, 2026
- Immune Globulin Intravenous (Human), 10% SolutionPhase 3 · Primary Immunodeficiency Diseases (PID)ClinicalTrials.gov · fetched Nov 12, 2026
- Immune Globulin Subcutaneous (Human), 20% SolutionPhase 3 · Primary Immunodeficiency Diseases (PID)ClinicalTrials.gov · fetched Nov 12, 2026
- ITIPhase 3 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- PEGylated Recombinant Factor VIIIPhase 3 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- rFVIIIPhase 3 · Von Willebrand Disease (VWD)ClinicalTrials.gov · fetched Nov 12, 2026
- rVWFPhase 3 · Von Willebrand Disease (VWD)ClinicalTrials.gov · fetched Nov 12, 2026
- TAK-755Phase 3 · Thrombotic Thrombocytopenic Purpura (TTP)ClinicalTrials.gov · fetched Nov 12, 2026
- Vonicog alfaPhase 3 · Von Willebrand DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- AskBio009Phase 2 · Hemophilia BClinicalTrials.gov · fetched Nov 12, 2026
- BAX 888Phase 2 · Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- BAX69 + 5-FU/LVPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- BAX69 + infusional 5-FU/LVPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- BAX69 + panitumumabPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- HYQVIAPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- ADYNOVI/ADYNOVATEHemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- Alpha1-proteinase inhibitorAlpha1-antitrypsin DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- ARALAST Alpha1-Proteinase InhibitorAlpha1-antitrypsin DeficiencyClinicalTrials.gov · fetched Nov 12, 2026
- Non-treatment, seroprevalenceHemophilia AClinicalTrials.gov · fetched Nov 12, 2026
- OBIZURAcquired Hemophilia AClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Oct 27, 2020ClinicalTrials.gov NCT04578535 · fetched Nov 12, 2026
- A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia AACTIVE_NOT_RECRUITING · started Jul 9, 2020ClinicalTrials.gov NCT04158934 · fetched Nov 12, 2026
- A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)PHASE3 · COMPLETED · started Apr 1, 2019ClinicalTrials.gov NCT03879135 · fetched Nov 12, 2026
- A Study of BAX 888 in Male Adults With Severe Hemophilia APHASE1_PHASE2 · COMPLETED · started Feb 27, 2018ClinicalTrials.gov NCT03370172 · fetched Nov 12, 2026
- A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)PHASE3 · COMPLETED · started Nov 6, 2017ClinicalTrials.gov NCT02932618 · fetched Nov 12, 2026
- A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)PHASE3 · COMPLETED · started Oct 13, 2017ClinicalTrials.gov NCT03393975 · fetched Nov 12, 2026
- Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD SubjectsPHASE3 · COMPLETED · started Sep 25, 2017ClinicalTrials.gov NCT03277313 · fetched Nov 12, 2026
- Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe HemophiliaCOMPLETED · started Jun 14, 2017ClinicalTrials.gov NCT03185897 · fetched Nov 12, 2026
- BAX 802 in CHA With InhibitorsPHASE3 · TERMINATED · started Dec 22, 2016ClinicalTrials.gov NCT02895945 · fetched Nov 12, 2026
- Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life PracticeCOMPLETED · started Dec 14, 2016ClinicalTrials.gov NCT03199794 · fetched Nov 12, 2026
- Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDPPHASE3 · COMPLETED · started Nov 14, 2016ClinicalTrials.gov NCT02955355 · fetched Nov 12, 2026
- GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage StudyPHASE3 · COMPLETED · started Mar 8, 2016ClinicalTrials.gov NCT02525861 · fetched Nov 12, 2026
- Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia ACOMPLETED · started Dec 30, 2015ClinicalTrials.gov NCT02610127 · fetched Nov 12, 2026
- A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)PHASE3 · COMPLETED · started Dec 15, 2015ClinicalTrials.gov NCT02549170 · fetched Nov 12, 2026
- A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia APHASE3 · COMPLETED · started Nov 12, 2015ClinicalTrials.gov NCT02615691 · fetched Nov 12, 2026
- Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)COMPLETED · started Nov 12, 2015ClinicalTrials.gov NCT02593188 · fetched Nov 12, 2026
- Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal CancerPHASE2 · TERMINATED · started Jun 15, 2015ClinicalTrials.gov NCT02448810 · fetched Nov 12, 2026
- Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia BPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Feb 11, 2013ClinicalTrials.gov NCT01687608 · fetched Nov 12, 2026
- Phase 2/3 Study of IGSC, 20% in PIDDPHASE2_PHASE3 · COMPLETED · started Jan 28, 2013ClinicalTrials.gov NCT01218438 · fetched Nov 12, 2026
- GLASSIA Infusion Rate StudyPHASE4 · COMPLETED · started Jul 31, 2012ClinicalTrials.gov NCT01651351 · fetched Nov 12, 2026
- Aralast alpha1-proteinase Inhibitor Surveillance StudyPHASE4 · TERMINATED · started Jun 9, 2006ClinicalTrials.gov NCT00313144 · fetched Nov 12, 2026
- Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia APHASE4 · COMPLETED · started Feb 2, 2006ClinicalTrials.gov NCT00289536 · fetched Nov 12, 2026
- Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency DisordersPHASE3 · COMPLETED · started Jun 25, 2002ClinicalTrials.gov NCT00157079 · fetched Nov 12, 2026
- Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901PHASE2_PHASE3 · COMPLETED · started Nov 22, 2001ClinicalTrials.gov NCT00157053 · fetched Nov 12, 2026
- Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing SurgeryPHASE2_PHASE3 · COMPLETED · started Feb 12, 2001ClinicalTrials.gov NCT00157105 · fetched Nov 12, 2026